With its world class research institutions, talent, and quality scientific outcomes, Canada is reputed to be an attractive place to engage in biotechnology. Showcasing new Canadian technologies emerging into the global marketplace. Exploring the financial investment and leadership resources it takes. Discovering the whys and why nots of how investors make decisions. Join a discussion to explore what is at play.

Host:  Andrew Casey, President and CEO, BIOTECanada 

Moderator: Didier Leconte, Vice President, Investments-Life Sciences and Funds Management, Fonds de solidarite 

Panelists:

Anne Woods, Managing Director, Silicon Valley Bank 

Dawn Bell, Global Development Head, Strategic Partnerships, Novartis 

Peter van der Velden, Managing Partner, Lumira Ventures 

Nancy Harrison, Venture Partner, Amplitude Ventures